Cargando…
Suppression of Soft Tissue Sarcoma Growth by a Host Defense-Like Lytic Peptide
BACKGROUND: Soft tissue sarcoma (STS) is an anatomically and histologically heterogeneous neoplasia that shares a putative mesenchymal cell origin. The treatment with common chemotherapeutics is still unsatisfying because of association with poor response rates. Although evidence is accumulating for...
Autores principales: | Steinstraesser, Lars, Hauk, Jennifer, Schubert, Cornelius, Al-Benna, Sammy, Stricker, Ingo, Hatt, Hanns, Shai, Yechiel, Steinau, Hans-Ulrich, Jacobsen, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069083/ https://www.ncbi.nlm.nih.gov/pubmed/21483840 http://dx.doi.org/10.1371/journal.pone.0018321 |
Ejemplares similares
-
Oncolytic Activities of Host Defense Peptides
por: Al-Benna, Sammy, et al.
Publicado: (2011) -
Biphasic Synovial Sarcoma of the Extremity: Quadruple Approach of Isolated Limb Perfusion, Surgical Ablation, Adipofascial Perforator Flap and Radiation to Avoid Amputation
por: Steinstraesser, Lars, et al.
Publicado: (2011) -
Brachial neuropathy 22 years after radiation therapy for fibrosarcoma: a case report
por: Al-Benna, Sammy, et al.
Publicado: (2009) -
Papillon-Lefèvre syndrome and squamous cell carcinoma: a case report
por: Al-Benna, Sammy, et al.
Publicado: (2009) -
Host Defense Peptides as Effector Molecules of the Innate Immune Response: A Sledgehammer for Drug Resistance?
por: Steinstraesser, Lars, et al.
Publicado: (2009)